Navigation Links


PharmaTech in Medical News

WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology

SHANGHAI, July 23 /PRNewswire-Asia/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Dr. Chi-Chung Chan has been appointed...

WuXi PharmaTech Files 2008 Annual Report on Form 20-F

SHANGHAI, June 25 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2008 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at h...

WuXi PharmaTech Announces First-Quarter 2009 Results

SHANGHAI, China, May 14 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financi...

WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance

SHANGHAI, May 5 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ) today announced that it has appointed Hao Zhou as Vice President of Finance. (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) Prior to joining WuXi PharmaTech, Mr. Zhou worked for eleven years at...

WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday, March 26, 2009

SHANGHAI, March 12 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quar...

WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO

SHANGHAI, Feb. 17 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ) announced today that Benson Tsang, Chief Financial Officer, is leaving the company for personal reasons at the end of February. Edward Hu, Chief Operating Officer, will serve as acting Chief Financial Officer until a replace...

WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 List for the Fifth Consecutive Year

SHANGHAI, China, Feb. 8 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is proud to announce that it was selected for the Deloitte Technol...

WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board

SHANGHAI, China, Feb. 5 /PRNewswire-Asia/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced the addition of Stewart Hen and Ning...

WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference

SHANGHAI, China, Nov. 27 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced Edward Hu, the Company's Chief Operatin...

WuXi PharmaTech Expands Collaboration for Fully Integrated Services

SHANGHAI, China, Oct. 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it has reached an agreement with J...
PharmaTech in Medical Technology

Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials

...ma, Chronic Myelogenous Leukemia, and Non-Small Cell Lung Cancer (NSCLC). pharmatech will manage the trials using its innovative JIT approach. This streamlined ...ion of approximately 165 Pharmatech Research Network sites. Matthew Wiener, pharmatech CEO, states that "The recent activity in new business has been a true testa...

Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial

... trial will also be supported by the Sarcoma Foundation of America (SFA). pharmatech will manage this sarcoma trial using its innovative Just-In-Time(TM) (JIT) ... the highest quality of clinical research, while protecting patient safety. pharmatech provides services of a Site Management Organization (SMO) and a Contract Re...

Quest PharmaTech's Prostate Cancer Program Update

...ical trial for the same indications. In addition, SL017 is currently undergoing a Canadian Phase I clinical trial for Actinic Keratosis. About Quest pharmatech Inc. The Corporation is a publicly traded , Alberta-based drug development company committed to the development and commercialization of new pharmac...
PharmaTech in Biological Technology

WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release

SHANGHAI, July 20 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quart...

WuXi PharmaTech Receives Award from BASF

SHANGHAI, July 1 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) announced today that it had received an award from BASF for excellent service and outstanding contributions in the area of custom synthesis for new crop-protection active ingredients. (Logo: http://www.ne...

WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise

SHANGHAI, June 29 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) announced today that it had been selected by China's Ministry of Commerce to the list of Top Ten Leading Outsourcing Enterprises in China. The list was announced at the Second Annual China International Service ...

WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations

SHANGHAI, June 22 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Felix Hsu has been appointed Senior ...

WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services

SHANGHAI, June 21 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Wei-Min Chang has been appointed Vic...

WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference

SHANGHAI, June 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) today announced that Edward Hu, the Company's Chief Operating Officer and acting Chief Financial Officer, will present at the Third Annual Jefferies Healthcare Conference in New York on Wednesday, June 17, 2009,...

WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release

Earnings Conference Call to be Held on May 15, 2009 at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) SHANGHAI, May 1 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing ...

WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results

SHANGHAI, March 25 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial re...

The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor

AURORA, Colo., March 18 /PRNewswire/ -- Pharmatech Oncology has been selected by the Fitzsimons Redevelopment Authority to be a preferred vendor to the Colorado Science + Technology Park at Fitzsimons. The Technology Park is home to 25 pharmaceutical and biotechnology companies. The majority of ...

Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052

TSX Venture: QPT EDMONTON, March 18 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer and dermatological conditions, today announced that it has formed a strategi...
Other TagsCOSCOSCOSCOSCOSCOSCOSCOS
(Date:11/29/2009)... DETROIT Using mannequins to teach doctors-in-tra... effective way to improve their skills without com...new study from Henry Ford Hospital. , The study ...an be a valuable tool to improve medical residents...ng some of the more common ultrasound-guided proce...
(Date:11/29/2009)... doctors unaware the sleep disorder boosts urine p... 29 (HealthDay News) -- People who wake up during ... a urological problem. Sleep apnea, a breathing-re...ew study suggests that nighttime urination, or noc...or obstructive sleep apnea, a disorder in which so...
(Date:11/28/2009)...at offenders were more likely to consider change a...nds , , FRIDAY, Nov. 27 (HealthDay News)...o consider why they should stop their dangerous be...anges, researchers have found. , The new study ...g-while-impaired convictions, who were randomly as...
(Date:11/27/2009)... Biotech firm Replikins Ltd. ...e H1N1 virus genomic data. It shows that the leth...7 (s.d. 4.5) during the virus,s current outbreak i...s this week of 2.0 (s.d. 0.1). The H1N1 infectivit... Boston (PRWEB) November 27, 2009 -- ...
(Date:11/27/2009)... , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire...q: SHMR ) ( "Shamir" ), a leading provider of inn...lens market, announced today that its board of dir...aggregate amount of US$ 10 million (approximately ...epresentative rate of exchange), or approximately ...
Breaking Medicine News(10 mins):Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3
(Date:11/23/2009)... A new study by the Wildlife Conservation Society ...ge swamp in the Republic of Congopart of the "moth...last yearare becoming increasingly threatened by g...y recommends protection of the swamp forests adjac...serve after recent surveys confirmed that high den...
(Date:11/23/2009)...armington, CT Current research suggests that a co...ase. The related report by Nichols et al, "Unique...New Class of TLR2 Ligands Capable of Enhancing Aut...The American Journal of Pathology . , Multiple ...attacks the brain and spinal cord, affects nearly ...
(Date:11/23/2009)... AMES, Iowa - The only swine vaccine available for... herd infected with the virus. The vaccination mar... herd diagnosed with the pandemic flu., Iowa Sta...cience, developed the vaccine this summer and has ...in Iowa, Kansas and Illinois for several weeks., ...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Advocates Debunk Misinformation Campaign Implore Governor to Veto SB 1122 48360 1Advocates Debunk Misinformation Campaign Implore Governor to Veto SB 1122 48360 2Advocates Debunk Misinformation Campaign Implore Governor to Veto SB 1122 48360 3TUG Procedure by Texas Health Dallas Cardiologist Offers Hope to Millions of Patients 48355 1TUG Procedure by Texas Health Dallas Cardiologist Offers Hope to Millions of Patients 48355 2Hypertension among lower status employees lingers well into retirement 8771 1Hypertension among lower status employees lingers well into retirement 8771 2Hypertension among lower status employees lingers well into retirement 8771 3
Other Contentscleancleancleancleancleancleancleancleancarecarecarecarecarecarecarecarecomputerscomputerscomputersrelationshiprelationshiprelationshiprelationshiprelationshiprelationshiprelationshiprelationshiprelationshipdoctordoctordoctordoctordoctordoctordoctordoctor